Dr. Agarwal’s Health Care subscription started on January 29th, 2025, and will close on January 31st, 2025, as per the schedule. The price band is set at ā¹382 to ā¹402 per share with a face value of ā¹1.
Dr. Agarwal’s Health Care IPO Subscription Status
Dr. Agarwal’s Health Care IPO Subscribed over 0.07x on its first day till 5.00 PM on 30th January 2025.Ā
- Dr. Agarwal’s Health Care IPO subscription QIB investors portion is 0 times, while NII subscribed 0.06 times and RII investors subscribed 0.12 times.
- The company has received bids for 39,04,460 shares against 5,35,26,172 shares on offer on the first day of subscription.
- Dr. Agarwal’s Health Care IPO subscribed over 0.07x on its first day.
About Dr. Agarwal’s Health Care Company
Dr. Agarwalās Health Care Limited founded in 2010, is one of the growing companies in the field of eye care-related pharmaceutical products. The company portfolio consists of a wide range of products and eye care services such as cataract, refractive, surgeries, consultations, diagnoses, non-surgical treatments, opticals, contact lenses, and many other accessories. Due to its exceptional operational history, the goal is to fulfill the needs of its patients in the eye care treatment journey making them feel safe and confident. As of March 31, 2024, the company comprises around 180 facilities. The Sale of optical, contact lenses and accessories are some of the eye care-related products they sell come under Primary facilities. At the same time, for services like cataract surgeries, Reconstructive surgeries, and other surgeries that come under Secondary Facilities. While surgical facilities consist of three centers of excellence (COEs) that come under Tertiary facilities. Their India presence comprises 26 hubs of tertiary facilities, including three COEs, and 139 spokes comprise 35 primary and 104 secondary facilities.
Dr. Agarwal’s Health Care Financial Report
The company reported revenue of ā¹1,376.45 crores in 2024 against ā¹1,031.49 crores in 2023. The company reported a profit of ā¹95.05 crores in 2024 against a Profit of ā¹103.23 crores in 2023.
Dr. Agarwal’s Health Care IPO GMP:
Dr. Agarwal’s Health Care IPO GMP was ā¹10 as of Wednesday, 29th January 2025. That indicates the IPO is trading at ā¹412 with ā¹10 premium in the grey market against the issue price of ā¹402.
